Quantum BioPharma Ltd. (QNTM)
2.82
-0.12
(-4.08%)
USD |
NASDAQ |
Oct 12, 16:00
2.81
-0.01
(-0.35%)
After-Hours: 20:00
Quantum BioPharma Total Liabilities (Quarterly) : 8.298M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.298M |
| March 31, 2026 | 16.35M |
| December 31, 2025 | 6.058M |
| September 30, 2025 | 6.646M |
| June 30, 2025 | 13.25M |
| March 31, 2025 | 10.34M |
| December 31, 2024 | 6.679M |
| September 30, 2024 | 3.681M |
| June 30, 2024 | 5.045M |
| March 31, 2024 | 3.924M |
| December 31, 2023 | 4.566M |
| September 30, 2023 | 4.195M |
| June 30, 2023 | 5.859M |
| March 31, 2023 | 8.623M |
| December 31, 2022 | 7.868M |
| September 30, 2022 | 7.439M |
| June 30, 2022 | 8.590M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.949M |
| December 31, 2021 | 8.832M |
| September 30, 2021 | 8.519M |
| June 30, 2021 | 10.07M |
| March 31, 2021 | 7.939M |
| December 31, 2020 | 5.659M |
| September 30, 2020 | 10.21M |
| June 30, 2020 | 4.552M |
| March 31, 2020 | 5.003M |
| December 31, 2019 | 6.940M |
| September 30, 2019 | 6.585M |
| June 30, 2019 | 3.478M |
| March 31, 2019 | 1.126M |
| December 31, 2018 | 1.277M |
| September 30, 2018 | 0.2219M |
| June 30, 2018 | 0.2341M |
| March 31, 2018 | 1.702M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Numinus Wellness, Inc. | 4.668M |
| Cocrystal Pharma, Inc. | 3.605M |
| Edesa Biotech, Inc. | 3.91M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| Invion Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.39M |
| Shareholders Equity (Quarterly) | 7.949M |
| Debt to Equity Ratio | 0.1212 |
| Current Ratio | 1.200 |
| Net Debt Paydown Yield | 0.23% |